Jeronimo Martins SGPS SA
ELI:JMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jeronimo Martins SGPS SA
ELI:JMT
|
PT |
|
Ra Medical Systems Inc
F:4RM
|
US |
|
M
|
Mitsubishi UFJ Financial Group Inc
XMUN:MFZ
|
JP |
|
Datagate Bilgisayar Malzemeleri Ticaret AS
IST:DGATE.E
|
TR |
|
D
|
Diageo PLC
XETRA:GUI
|
UK |
|
U
|
US Critical Metals Corp
OTC:USCMF
|
CA |
|
Elton International Trading Company SA
F:Y1O
|
GR |
|
F
|
First International Bank of Israel Ltd
TASE:FIBI
|
IL |
|
A
|
Avolta AG
XMUN:D2J
|
CH |
Earnings Calls
Last Earnings Call
Solid half-year: Jerónimo Martins said first-half 2026 was tougher than expected, but the group still delivered sales of EUR 18.3 billion, up 5.1%, and EBITDA of EUR 1.2 billion, up 7.6%.
Poland deflation: Biedronka faced heavy basket deflation and a very competitive Polish market, but volume growth of around 5% helped preserve market share and keep sales positive.
Margins held up: Every banner improved EBITDA margin, with the group margin rising to 6.8% from 6.6%, helped mainly by better mix, tighter cost control and efficiency gains.
Outlook cautious: Management does not expect a material improvement in market conditions in the second half and said consumers will likely stay focused on low prices and promotions.
Cash and investment: Cash flow before dividends was negative at EUR 332 million, weighed down by deflation and working capital, while CapEx totaled EUR 412 million and the full-year investment plan remains capped at around EUR 1.2 billion.